Please provide your email address to receive an email when new articles are posted on . Women screened for cervical cancer via primary HPV testing had a lower likelihood of developing grade 3 cervical ...

Roche’s CINtec PLUS Cytology is the only FDA-approved and CE-marked dual-stain test to triage human papillomavirus (HPV)-positive cervical cancer screening test results Dual-stain biomarkers aid in ...

Please provide your email address to receive an email when new articles are posted on . HPV-based vs. cytology-based screening was tied to lower risks for invasive cervical cancer. Adverse events were ...

A cervical polyp is a growth that develops on the cervix, which is the canal connecting the uterus to the vagina. Sperm must pass through this canal to fertilize an egg. Cervical polyps are tumors, ...

We included 717 cancers from 23 studies. The pooled sensitivity of cytology to cancer at a cutoff of a high-grade squamous intraepithelial lesion (HSIL) or worse was 79.4% (95% CI, 67.7% to 86.0%).

TUCSON, Ariz., June 16, 2015 /PRNewswire/ -- Ventana Medical Systems, Inc. (Ventana), a member of the Roche Group, today announced the publication of further results from the Primary ASC-US LSIL ...

Cervical cancer has historically been a significant public health issue worldwide, causing substantial morbidity and mortality among women. Over recent decades, advances in screening, vaccination, and ...

DNA testing for the two most common types of cancer-causing HPV detects the most risky cervical lesions better than liquid-based cytology, data from the ATHENA trial indicate. Detecting HPV-16 and HPV ...

Final results of a chemoprevention trial with enzastaurin in former smokers. Background: Concurrent HPV testing and cervical cytology (co-testing) is an approved and promising alternative to cytology ...